Balance of GAD65-Specific IL-10 Production and Polyclonal Thl-Type Response in Type 1 Diabetes

References

• Shimada A, Rohane P W, Fathman C G, Charlton B. Pathogenic and protective roles of CD45RBlow CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 1996; 45: 71–78
   PubMed Web of Science ®Google Scholar
• Rabinovitch A. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Diabetes 1994; 43: 613–621
   PubMed Web of Science ®Google Scholar
• Rapoport M, Jaramillo A, Zipris D, Lazarus A, Serreze D, Leiter E, Cyopick P, Danska J, Delovitch T. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993; 178: 87–99
   PubMed Web of Science ®Google Scholar
• Nitta Y, Tashiro F, Tokui M, Shimada A, Takei I, Tabayashi K, Miyazaki J. Systemic delivery of interleukin 10 by intramuscular injection of expression plasmid DNA prevents autoimmune diabetes in nonobese diabetic mice. Hum Gene Ther 1998; 9: 1701–7
   PubMed Web of Science ®Google Scholar
• Katz J D, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science 1994; 268: 1185–1188
   Web of Science ®Google Scholar
• Myltenyi S, Muller W, Weichel W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 1990; 11: 231–238
   PubMedGoogle Scholar
• Shimada A, Charlton B, Edwards C. T., Fathman C G. P-Cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes 1996; 45: 1063–1067
   PubMed Web of Science ®Google Scholar
• Fitch F W, Lancki D W, Gajewski T F. T-cell mediated immune regulation. In Fundamental Immunology edited by Paul WE 1993; 733–761
   Google Scholar
• Harrison L C, Honeyman M C, Trembleau S, Gregori S, Gallazzi F, Augstein P., et al. A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi ABJ H mice. J Exp Med 1997; 185: 1013–1021
   PubMed Web of Science ®Google Scholar
• Harrison L C, Dempsey-Collier M, Kramer D R, Takahashi K. Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J Exp Med 1996; 184: 2167–2174
   PubMedGoogle Scholar
• Yoon J W, Yoon C S, Lim H W, Huang Q Q, Kang Y, Pyun K. H., et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β″ cells. Science 1999; 284: 1183–1187
   PubMed Web of Science ®Google Scholar
• Kaufman D L, Clare-Satzler M, Tian J, Fosthuber T, Ting G SP, Robinson P., et al. Spontaneouse loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependant diabetes. Nature 1993; 366: 69–72
   PubMed Web of Science ®Google Scholar
• Tishe R, Yang X D, Sing S M, Liblau R S, Fugger L, McDevitt H O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366: 72–75
   PubMed Web of Science ®Google Scholar
• Quinn A, Sercarz E E. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD (524-543). J Autoimmun 1996; 9: 365–370
   PubMed Web of Science ®Google Scholar
• Sai P, Rivereau S, Granier C, Haertle T H, Martignat L. Immunizationof non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes. Clin Exp Immunol 1996; 105: 330–337
   PubMed Web of Science ®Google Scholar
• Kash S F, Condie B G, Baekkeskov S. Glutamate decarboxylase and GABA in pancreatic islet: lessons from knock-out mice. Horm Metab Res 1999; 31: 340–344
   PubMed Web of Science ®Google Scholar
• Plesner A, Worsaae A, Dyrberg T, Gotfredsen C, Michelsen B K, Petersen J S. Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology. J Autoimmun 1998; 11: 335–341
   PubMed Web of Science ®Google Scholar
• Bendelac A, Carnaud C, Boitard C, Bach J F. Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 1987; 166: 823–32
   PubMed Web of Science ®Google Scholar
• Wicker L S, Miller B J, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986; 35: 855–60
   PubMed Web of Science ®Google Scholar
• Tian J, Salzler M C, Herschenfeld A, Middleton B, Newman D, Mueller R., et al. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat Med 1996; 2: 1348–1353
   PubMed Web of Science ®Google Scholar
• Tokui M, Shimada A, Takei I, Kasuga A, Funae O, Morim-Oto J., et al. Suppressive effect on diabetes development in autoimmune diabetic mice by intramuscular injection of plas-mid DNA expressing GAD and IL-4 (Abstract). Diabetes 1998; 47(suppl. 1)A224
   PubMedGoogle Scholar
• Trembleau S, Penna G, Bosi E, Mortara A, Gately M K, Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995; 181: 817–821
   PubMed Web of Science ®Google Scholar
• Rothe H, Faust A, Schade U, Kleemann R, Bosse G, Hibino T., et al. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of inter-leukin-4. Diabetologia 1994; 37: 1154–1158
   PubMed Web of Science ®Google Scholar
• Rothe H, Hibino T, Itoh Y, Kolb H, Martin S. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-γ expression involved in the development of Thl insulitis in NOD mice. J Autoimmun 1997; 10: 251–256
   PubMed Web of Science ®Google Scholar
• Morimoto J, Shimada A, Tokui M, Funae O, Kasuga A, Nomaguchi H., et al. In vivo anti-IL-18 monoclonal antibody treatment suppresses cyclophosphamide-induced diabetes in NOD mice (Abstract). Diabetes 1999; 48(suppl. 1)A216
   Google Scholar